Results 221 to 230 of about 1,615,665 (249)
Some of the next articles are maybe not open access.

Epoprostenol in pulmonary arterial hypertension

Expert Opinion on Drug Metabolism & Toxicology, 2008
Pulmonary arterial hypertension (PAH) is a devastating disease leading to right heart failure and death in a relatively young patient population. In recent years novel PAH specific therapies have become available.To determine the place of epoprostenol in current PAH treatment strategies.An extensive Medline search was performed to evaluate the use of ...
Jacobs, W., Vonk Noordegraaf, A.
openaire   +3 more sources

Sildenafil for Pulmonary Arterial Hypertension

American Journal of Therapeutics, 2019
Pulmonary hypertension is a life-threatening illness with debilitating physical and emotional consequences. The progression of this devastating disease is characterized by a continuous increase in pulmonary vascular resistance, which results in elevated pulmonary artery pressure and leads to right heart failure.
Bhogal, Sukhdeep   +5 more
openaire   +3 more sources

Pulmonary Arterial Hypertension

Cardiology in Review, 2015
Pulmonary arterial hypertension (PAH) is a progressive disease that remains incurable. The past 2 decades have witnessed many advances in PAH-directed therapies. More recently, 3 new oral agents have become available in the United States within the past 2 years. Treprostinil is now available in extended-release oral tablets.
Bhaumik B, Patel   +2 more
openaire   +2 more sources

Pulmonary Arterial Hypertension in Portal Hypertension

Clinics in Gastroenterology, 1985
Frequence d'estimation difficile; hypertension pulmonaire due a la cirrhose de differentes origines ou consequence d'anastomose porto-cave. Anatomopathologie des vaisseaux pulmonaires. Nature de l'hypertension portale. Etude clinique.
openaire   +2 more sources

Pulmonary Arterial Hypertension: An Overview

Seminars in Cardiothoracic and Vascular Anesthesia, 2007
Pulmonary arterial hypertension (PAH) was first described over 100 years ago, but a thorough understanding of its patho-genesis and a successful approach to curing the disease remain elusive. Increased research activity has greatly enhanced our understanding of the disease and led to new therapies that retard disease progression and improve patient ...
openaire   +2 more sources

Pathology of Pulmonary Arterial Hypertension

Seminars in Respiratory and Critical Care Medicine, 2009
The pathological features of pulmonary arterial hypertension are highlighted in this review, which can serve as a guide to diagnosis and identification of potential cellular targets for novel lines of therapy. It also emphasizes the variability of pathological processes found in pulmonary hypertensive lungs collected by the Pulmonary Breakthrough ...
openaire   +2 more sources

Epigenetics of Pulmonary Diseases

Medical Epigenetics, 2021
Narasaiah Kolliputi
exaly  

Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension

New England Journal of Medicine, 2023
Marius M Hoeper   +2 more
exaly  

Sotatercept for the Treatment of Pulmonary Arterial Hypertension

New England Journal of Medicine, 2021
J Simon R Gibbs   +2 more
exaly  

Treatment of Pulmonary Arterial Hypertension

New England Journal of Medicine, 2004
Olivier Sitbon   +2 more
exaly  

Home - About - Disclaimer - Privacy